FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Brainbees Solutions (Firstcry) IPO and Emcure Pharma IPO.
Brainbees Solutions (Firstcry) IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Brainbees Solutions (Firstcry) IPO | Emcure Pharma IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Kotak Mahindra Capital Company Limited Morgan Stanley India Company Pvt Ltd Bofa Securities India Limited Jm Financial Limited Avendus Capital Pvt Ltd |
Kotak Mahindra Capital Company Limited Axis Capital Limited J.P. Morgan India Private Limited Jefferies India Private Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Brainbees Solutions (Firstcry) IPO is up to ₹4,193.73 Cr whereas the issue size of the Emcure Pharma IPO is up to ₹1,952.03 Cr. The final issue price of Brainbees Solutions (Firstcry) IPO is ₹465.00 per share and of Emcure Pharma IPO is ₹1,008.00 per share.
Brainbees Solutions (Firstcry) IPO | Emcure Pharma IPO | |
---|---|---|
Face Value | ₹2 per share | ₹10 per share |
Issue Price (Lower) | ₹440.00 per share | ₹960.00 per share |
Issue Price (Upper) | ₹465.00 per share | ₹1,008.00 per share |
Issue Price (Final) | ₹465.00 per share | ₹1,008.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹44.00 per share | ₹90.00 per share |
Market Lot Size | 32 shares | 14 shares |
Fresh Issue Size | 3,58,27,957 shares | 79,36,507 shares |
Fresh Issue Size (Amount) | up to ₹1,666.00 Cr | up to ₹800.00 Cr |
OFS Issue Size | 5,43,59,733 shares | 1,14,28,839 shares |
OFS Issue Size (Amount) | up to ₹2,527.73 Cr | up to ₹1,152.03 Cr |
Issue Size Total | 9,01,87,690 shares | 1,93,65,346 shares |
Issue Size Total (Amount) | up to ₹4,193.73 Cr | up to ₹1,952.03 Cr |
Brainbees Solutions (Firstcry) IPO opens on Aug 06, 2024, while Emcure Pharma IPO opens on Jul 03, 2024. The closing date of Brainbees Solutions (Firstcry) IPO and Emcure Pharma IPO is Aug 08, 2024, and Jul 05, 2024, respectively.
Brainbees Solutions (Firstcry) IPO | Emcure Pharma IPO | |
---|---|---|
Anchor Bid Date | Aug 05, 2024 | Jul 02, 2024 |
Issue Open | Aug 06, 2024 | Jul 03, 2024 |
Issue Close | Aug 08, 2024 | Jul 05, 2024 |
Basis Of Allotment (Tentative) | Aug 09, 2024 | Jul 08, 2024 |
Initiation of Refunds (Tentative) | Aug 12, 2024 | Jul 09, 2024 |
Credit of Share (Tentative) | Aug 12, 2024 | Jul 09, 2024 |
Listing date (Tentative) | Aug 13, 2024 | Jul 10, 2024 |
Anchor Lockin End date 1 | Sep 08, 2024 | Aug 07, 2024 |
Anchor Lockin End date 2 | Nov 07, 2024 | Oct 06, 2024 |
Brainbees Solutions (Firstcry) IPO P/E ratio is -69.91, as compared to Emcure Pharma IPO P/E ratio of 34.55.
Brainbees Solutions (Firstcry) IPO | Emcure Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Brainbees Solutions Limited Financial Information (Restated Consolidated)Brainbees Solutions Limited's revenue increased by 14.72% and profit after tax (PAT) rose by 33.85% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 98.90% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 78.24% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | -69.91 | 34.55 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹24141.75 Cr. | ₹19029.89 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 16.90%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 19.37%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.67 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹-6.65 | ₹29.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | -8.65%% | 16.87%% |
In the Brainbees Solutions (Firstcry) IPO retail investors (RII) are offered 90,12,317 shares while in Emcure Pharma IPO retail investors are offered 90,12,317 shares. Qualified institutional buyers (QIB) are offered 2,70,36,953 shares in Brainbees Solutions (Firstcry) IPO and 38,53,234 shares in Emcure Pharma IPO.
Brainbees Solutions (Firstcry) IPO | Emcure Pharma IPO | |
---|---|---|
Anchor Investor Reserveration | 4,05,55,428 shares | 57,79,850 shares |
Market Maker Reserveration | ||
QIB | 2,70,36,953 shares | 38,53,234 shares |
NII | 1,35,18,476 shares | 28,89,926 shares |
RII | 90,12,317 shares | 67,43,160 shares |
Employee | 71,258 shares | 1,08,900 shares |
Others | ||
Total | 4,96,39,004 shares | 1,37,03,538 shares |
Brainbees Solutions (Firstcry) IPO subscribed 12.22x in total, whereas Emcure Pharma IPO subscribed 67.87x.
Brainbees Solutions (Firstcry) IPO | Emcure Pharma IPO | |
---|---|---|
QIB (times) | 19.30x | 191.24x |
NII (times) | 4.68x | 49.32x |
Big NII (times) | 5.32x | 54.90x |
Small NII (times) | 3.39x | 38.16x |
RII (times) | 2.31x | 7.36x |
Employee (times) | 6.57x | 8.81x |
Other (times) | ||
Total (times) | 12.22x | 67.87x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|